Overlapping and Distinct Features of Cardiac Pathology in Inherited Human and Murine Ether Lipid Deficiency.
Fabian DorningerAttila KissPeter RothauerAlexander Stiglbauer-TscholakoffStefan KummerWedad FallatahMireia Perera-GonzalezOuafa HamzaTheresa KönigMichael B BoberTiscar Cavallé-GarridoNancy E BravermanSonja Forss-PetterChristian PiflJan BauerReginald E BittnerThomas H HelbichBruno Karl PodesserHannes TodtJohannes BergerPublished in: International journal of molecular sciences (2023)
Inherited deficiency in ether lipids, a subgroup of glycerophospholipids with unique biochemical and biophysical properties, evokes severe symptoms in humans resulting in a multi-organ syndrome. Mouse models with defects in ether lipid biosynthesis have widely been used to understand the pathophysiology of human disease and to study the roles of ether lipids in various cell types and tissues. However, little is known about the function of these lipids in cardiac tissue. Previous studies included case reports of cardiac defects in ether-lipid-deficient patients, but a systematic analysis of the impact of ether lipid deficiency on the mammalian heart is still missing. Here, we utilize a mouse model of complete ether lipid deficiency ( Gnpat KO) to accomplish this task. Similar to a subgroup of human patients with rhizomelic chondrodysplasia punctata (RCDP), a fraction of Gnpat KO fetuses present with defects in ventricular septation, presumably evoked by a developmental delay. We did not detect any signs of cardiomyopathy but identified increased left ventricular end-systolic and end-diastolic pressure in middle-aged ether-lipid-deficient mice. By comprehensive electrocardiographic characterization, we consistently found reduced ventricular conduction velocity, as indicated by a prolonged QRS complex, as well as increased QRS and QT dispersion in the Gnpat KO group. Furthermore, a shift of the Wenckebach point to longer cycle lengths indicated depressed atrioventricular nodal function. To complement our findings in mice, we analyzed medical records and performed electrocardiography in ether-lipid-deficient human patients, which, in contrast to the murine phenotype, indicated a trend towards shortened QT intervals. Taken together, our findings demonstrate that the cardiac phenotype upon ether lipid deficiency is highly heterogeneous, and although the manifestations in the mouse model only partially match the abnormalities in human patients, the results add to our understanding of the physiological role of ether lipids and emphasize their importance for proper cardiac development and function.
Keyphrases
- left ventricular
- endothelial cells
- mouse model
- end stage renal disease
- fatty acid
- heart failure
- ionic liquid
- ejection fraction
- newly diagnosed
- cardiac resynchronization therapy
- chronic kidney disease
- hypertrophic cardiomyopathy
- prognostic factors
- peritoneal dialysis
- induced pluripotent stem cells
- blood pressure
- left atrial
- gene expression
- healthcare
- magnetic resonance imaging
- mesenchymal stem cells
- type diabetes
- aortic stenosis
- middle aged
- magnetic resonance
- clinical trial
- open label
- drug induced
- preterm birth
- computed tomography
- physical activity
- depressive symptoms
- patient reported
- rectal cancer
- single cell
- locally advanced